Netherlands Cancer Institute

The technology quantifies the efficacy of genome-editing methods and identifies the predominant types of insertions and deletions in a targeted pool of cells.

The competition was established in 2015 to fund studies addressing the biggest challenges in cancer research.

Using exome sequencing, researchers unearthed apparent anti-PD-1 resistance mutations in three of four individuals treated for metastatic melanoma.

The seven-parameter proposal potentially offers a way to assess how the immune system and a cancer interact on a broader level in order to better guide treatment.

NEW YORK (GenomeWeb News) – A group of Dutch-led research partners will use a €1.2 million ($1.5 million) grant awarded under a collaboration with Stand Up 2 Cancer (SU2C) to fund a genomics-based project seeking to use tumor profiles to predict patient response to cancer treatments.

"We will use multiple 'omics' technologies to ask which kinase signaling pathways are activated in colon cancer," an Agendia spokesperson said of the collaboration, which will also provide independent validation of the company's ColoPrint colon cancer recurrence test.

The partners will use an integrated approach combining genomics and proteomics to better understand colorectal cancer biology.

The partners will seek to identify specific colorectal cancer subtypes in order to develop targeted therapies.

Sometimes genetic tests give inconclusive results and provide little reassurance to patients, the Associated Press reports.

Vox wonders whether gene-editing crops will be viewed similarly as genetically modified organisms of if people will give them a try.

In Science this week: research regulation and reporting requirement reform, and more.

With H3Africa, Charles Rotimi has been working to bolster the representation of African participants and African researchers in genomics, Newsweek reports.